Cargando…

AntiPORT: adaptation of a transfusion prediction score to an Australian cardiac surgery population

Introduction: Risk scoring systems exist to predict perioperative blood transfusion risk in cardiac surgery, but none have been validated in the Australian or New Zealand population. The ACTA-PORT score was developed in the United Kingdom for this purpose. In this study, we validate and recalibrate...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeates, James, Miles, Lachlan, Blatchford, Kate, Bailey, Michael, Williams-Spence, Jenni, Reid, Christopher, Coulson, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692639/
https://www.ncbi.nlm.nih.gov/pubmed/38047003
http://dx.doi.org/10.51893/2022.4.OA6
_version_ 1785152987350433792
author Yeates, James
Miles, Lachlan
Blatchford, Kate
Bailey, Michael
Williams-Spence, Jenni
Reid, Christopher
Coulson, Tim
author_facet Yeates, James
Miles, Lachlan
Blatchford, Kate
Bailey, Michael
Williams-Spence, Jenni
Reid, Christopher
Coulson, Tim
author_sort Yeates, James
collection PubMed
description Introduction: Risk scoring systems exist to predict perioperative blood transfusion risk in cardiac surgery, but none have been validated in the Australian or New Zealand population. The ACTA-PORT score was developed in the United Kingdom for this purpose. In this study, we validate and recalibrate the ACTA-PORT score in a large national database. Methods: We performed a retrospective validation study using data from the Australian and New Zealand Society of Cardiac and Thoracic Surgeons Database between 1 September 2016 and 31 December 2018. The ACTA-PORT score was calculated using an equivalent of EuroSCORE I. Discrimination and calibration was assessed using area under the receiver operating characteristic (AUROC) curves, Brier scores, and calibration plots. ACTA-PORT was then recalibrated in a development set using logistic regression and the outcome of transfusion to develop new predicted transfusion rates, termed "AntiPORT”, using AusSCORE "all procedures" as the regional equivalent of EuroSCORE I. The accuracy of these new predictions was assessed as for ACTA-PORT. Results: 30 388 patients were included in the study at 37 Australian centres. The rate of red blood cell transfusion was 33%. Discrimination of ACTA-PORT was good but calibration was poor, with overprediction of transfusion (AUROC curve, 0.76; 95% CI, 0.75-0.76; Brier score, 0.19). The recalibrated AntiPORT showed significantly improved calibration in both development and validation sets without compromising discrimination (AUROC curve, 0.76; 95% CI, 0.75-0.76; Brier score, 0.18). Conclusions: The AntiPORT is the first red cell transfusion risk scoring system for cardiac surgery patients to be validated using Australian data. It is accurate and simple to calculate. The demonstrated accuracy of AntiPORT may help facilitate benchmarking and future research in patient blood management, as well as providing a useful tool to help clinicians target these resource-saving strategies.
format Online
Article
Text
id pubmed-10692639
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-106926392023-12-03 AntiPORT: adaptation of a transfusion prediction score to an Australian cardiac surgery population Yeates, James Miles, Lachlan Blatchford, Kate Bailey, Michael Williams-Spence, Jenni Reid, Christopher Coulson, Tim Crit Care Resusc Orginal Articles Introduction: Risk scoring systems exist to predict perioperative blood transfusion risk in cardiac surgery, but none have been validated in the Australian or New Zealand population. The ACTA-PORT score was developed in the United Kingdom for this purpose. In this study, we validate and recalibrate the ACTA-PORT score in a large national database. Methods: We performed a retrospective validation study using data from the Australian and New Zealand Society of Cardiac and Thoracic Surgeons Database between 1 September 2016 and 31 December 2018. The ACTA-PORT score was calculated using an equivalent of EuroSCORE I. Discrimination and calibration was assessed using area under the receiver operating characteristic (AUROC) curves, Brier scores, and calibration plots. ACTA-PORT was then recalibrated in a development set using logistic regression and the outcome of transfusion to develop new predicted transfusion rates, termed "AntiPORT”, using AusSCORE "all procedures" as the regional equivalent of EuroSCORE I. The accuracy of these new predictions was assessed as for ACTA-PORT. Results: 30 388 patients were included in the study at 37 Australian centres. The rate of red blood cell transfusion was 33%. Discrimination of ACTA-PORT was good but calibration was poor, with overprediction of transfusion (AUROC curve, 0.76; 95% CI, 0.75-0.76; Brier score, 0.19). The recalibrated AntiPORT showed significantly improved calibration in both development and validation sets without compromising discrimination (AUROC curve, 0.76; 95% CI, 0.75-0.76; Brier score, 0.18). Conclusions: The AntiPORT is the first red cell transfusion risk scoring system for cardiac surgery patients to be validated using Australian data. It is accurate and simple to calculate. The demonstrated accuracy of AntiPORT may help facilitate benchmarking and future research in patient blood management, as well as providing a useful tool to help clinicians target these resource-saving strategies. Elsevier 2023-10-16 /pmc/articles/PMC10692639/ /pubmed/38047003 http://dx.doi.org/10.51893/2022.4.OA6 Text en © 2022 College of Intensive Care Medicine of Australia and New Zealand. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Orginal Articles
Yeates, James
Miles, Lachlan
Blatchford, Kate
Bailey, Michael
Williams-Spence, Jenni
Reid, Christopher
Coulson, Tim
AntiPORT: adaptation of a transfusion prediction score to an Australian cardiac surgery population
title AntiPORT: adaptation of a transfusion prediction score to an Australian cardiac surgery population
title_full AntiPORT: adaptation of a transfusion prediction score to an Australian cardiac surgery population
title_fullStr AntiPORT: adaptation of a transfusion prediction score to an Australian cardiac surgery population
title_full_unstemmed AntiPORT: adaptation of a transfusion prediction score to an Australian cardiac surgery population
title_short AntiPORT: adaptation of a transfusion prediction score to an Australian cardiac surgery population
title_sort antiport: adaptation of a transfusion prediction score to an australian cardiac surgery population
topic Orginal Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692639/
https://www.ncbi.nlm.nih.gov/pubmed/38047003
http://dx.doi.org/10.51893/2022.4.OA6
work_keys_str_mv AT yeatesjames antiportadaptationofatransfusionpredictionscoretoanaustraliancardiacsurgerypopulation
AT mileslachlan antiportadaptationofatransfusionpredictionscoretoanaustraliancardiacsurgerypopulation
AT blatchfordkate antiportadaptationofatransfusionpredictionscoretoanaustraliancardiacsurgerypopulation
AT baileymichael antiportadaptationofatransfusionpredictionscoretoanaustraliancardiacsurgerypopulation
AT williamsspencejenni antiportadaptationofatransfusionpredictionscoretoanaustraliancardiacsurgerypopulation
AT reidchristopher antiportadaptationofatransfusionpredictionscoretoanaustraliancardiacsurgerypopulation
AT coulsontim antiportadaptationofatransfusionpredictionscoretoanaustraliancardiacsurgerypopulation